Acorda Therapeutics Inc Preço/Vendas
Qual é o Preço/Vendas de Acorda Therapeutics Inc?
O Preço/Vendas de Acorda Therapeutics Inc é 0.11
Qual é a definição de Preço/Vendas?
A razão entre preço e vendas é o preço das ações de uma empresa em comparação com as suas receitas.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Preço/Vendas de empresas na Setor Health Care em NASDAQ em comparação com Acorda Therapeutics Inc
O que Acorda Therapeutics Inc faz?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Empresas com preço/vendas semelhantes a Acorda Therapeutics Inc
- Sakuma Exports tem Preço/Vendas de 0.11
- ATOS SE tem Preço/Vendas de 0.11
- BRF S.A tem Preço/Vendas de 0.11
- Guan Chao tem Preço/Vendas de 0.11
- TCL Electronics tem Preço/Vendas de 0.11
- TClarke Plc tem Preço/Vendas de 0.11
- Acorda Therapeutics Inc tem Preço/Vendas de 0.11
- Sintex Industries tem Preço/Vendas de 0.11
- Kisan Mouldings tem Preço/Vendas de 0.11
- EVRAZ Plc tem Preço/Vendas de 0.11
- Transtech Optelecom Science tem Preço/Vendas de 0.11
- ParcelPal Technology tem Preço/Vendas de 0.11
- Hong Kong Johnson Hldg Co Ltd tem Preço/Vendas de 0.11